Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

The quality of cortical network function recovery depends on localization and degree of axonal demyelination.

Cerina M, Narayanan V, Göbel K, Bittner S, Ruck T, Meuth P, Herrmann AM, Stangel M, Gudi V, Skripuletz T, Daldrup T, Wiendl H, Seidenbecher T, Ehling P, Kleinschnitz C, Pape HC, Budde T, Meuth SG.

Brain Behav Immun. 2017 Jan;59:103-117. doi: 10.1016/j.bbi.2016.08.014. Epub 2016 Aug 25.

2.

Impairment of frequency-specific responses associated with altered electrical activity patterns in auditory thalamus following focal and general demyelination.

Narayanan V, Cerina M, Göbel K, Meuth P, Herrmann AM, Fernandez-Orth J, Stangel M, Gudi V, Skripuletz T, Daldrup T, Lesting J, Schiffler P, Wiendl H, Seidenbecher T, Meuth SG, Budde T, Pape HC.

Exp Neurol. 2018 Nov;309:54-66. doi: 10.1016/j.expneurol.2018.07.010. Epub 2018 Jul 23.

PMID:
30048715
3.

Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.

Guglielmetti C, Veraart J, Roelant E, Mai Z, Daans J, Van Audekerke J, Naeyaert M, Vanhoutte G, Delgado Y Palacios R, Praet J, Fieremans E, Ponsaerts P, Sijbers J, Van der Linden A, Verhoye M.

Neuroimage. 2016 Jan 15;125:363-377. doi: 10.1016/j.neuroimage.2015.10.052. Epub 2015 Oct 23.

4.

Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Goldberg J, Clarner T, Beyer C, Kipp M.

J Mol Neurosci. 2015 Oct;57(2):166-75. doi: 10.1007/s12031-015-0595-5. Epub 2015 Jun 12.

PMID:
26067430
5.

The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Tejedor LS, Wostradowski T, Gingele S, Skripuletz T, Gudi V, Stangel M.

J Mol Neurosci. 2017 Apr;61(4):479-488. doi: 10.1007/s12031-017-0888-y. Epub 2017 Jan 26.

PMID:
28124770
6.

Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.

Große-Veldmann R, Becker B, Amor S, van der Valk P, Beyer C, Kipp M.

Mol Neurobiol. 2016 Sep;53(7):4905-17. doi: 10.1007/s12035-015-9420-y. Epub 2015 Sep 12.

PMID:
26363796
7.

Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination.

Silvestroff L, Bartucci S, Pasquini J, Franco P.

Exp Neurol. 2012 May;235(1):357-67. doi: 10.1016/j.expneurol.2012.02.018. Epub 2012 Mar 7.

PMID:
22421533
8.

Cerebellar cortical demyelination in the murine cuprizone model.

Skripuletz T, Bussmann JH, Gudi V, Koutsoudaki PN, Pul R, Moharregh-Khiabani D, Lindner M, Stangel M.

Brain Pathol. 2010 Mar;20(2):301-12. doi: 10.1111/j.1750-3639.2009.00271.x. Epub 2009 Apr 7.

PMID:
19371354
9.

Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.

Schultz V, van der Meer F, Wrzos C, Scheidt U, Bahn E, Stadelmann C, Brück W, Junker A.

Glia. 2017 Aug;65(8):1350-1360. doi: 10.1002/glia.23167. Epub 2017 May 31.

10.

Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.

Baxi EG, DeBruin J, Jin J, Strasburger HJ, Smith MD, Orthmann-Murphy JL, Schott JT, Fairchild AN, Bergles DE, Calabresi PA.

Glia. 2017 Dec;65(12):2087-2098. doi: 10.1002/glia.23229. Epub 2017 Sep 22.

11.

Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Steelman AJ, Thompson JP, Li J.

Neurosci Res. 2012 Jan;72(1):32-42. doi: 10.1016/j.neures.2011.10.002. Epub 2011 Oct 12.

12.

Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.

Llufriu-Dabén G, Carrete A, Chierto E, Mailleux J, Camand E, Simon A, Vanmierlo T, Rose C, Allinquant B, Hendriks JJA, Massaad C, Meffre D, Jafarian-Tehrani M.

Neurobiol Dis. 2018 Jan;109(Pt A):11-24. doi: 10.1016/j.nbd.2017.09.008. Epub 2017 Sep 18.

PMID:
28923597
13.

Thalamocortical-auditory network alterations following cuprizone-induced demyelination.

Ghaffarian N, Mesgari M, Cerina M, Göbel K, Budde T, Speckmann EJ, Meuth SG, Gorji A.

J Neuroinflammation. 2016 Jun 22;13(1):160. doi: 10.1186/s12974-016-0629-0.

14.

Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.

Janssen K, Rickert M, Clarner T, Beyer C, Kipp M.

Mol Neurobiol. 2016 Apr;53(3):1551-1564. doi: 10.1007/s12035-015-9113-6. Epub 2015 Feb 8.

PMID:
25663168
15.

rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.

Mullin AP, Cui C, Wang Y, Wang J, Troy E, Caggiano AO, Parry TJ, Colburn RW, Pavlopoulos E.

Neurobiol Dis. 2017 Sep;105:142-155. doi: 10.1016/j.nbd.2017.05.015. Epub 2017 May 30.

16.

Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.

Zhang M, Zhan XL, Ma ZY, Chen XS, Cai QY, Yao ZX.

Exp Biol Med (Maywood). 2015 Sep;240(9):1183-96. doi: 10.1177/1535370214565975. Epub 2015 Jan 10.

17.

Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Skripuletz T, Lindner M, Kotsiari A, Garde N, Fokuhl J, Linsmeier F, Trebst C, Stangel M.

Am J Pathol. 2008 Apr;172(4):1053-61. doi: 10.2353/ajpath.2008.070850. Epub 2008 Mar 18.

18.

In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.

Jelescu IO, Zurek M, Winters KV, Veraart J, Rajaratnam A, Kim NS, Babb JS, Shepherd TM, Novikov DS, Kim SG, Fieremans E.

Neuroimage. 2016 May 15;132:104-114. doi: 10.1016/j.neuroimage.2016.02.004. Epub 2016 Feb 11.

19.
20.

A mouse model for testing remyelinating therapies.

Bai CB, Sun S, Roholt A, Benson E, Edberg D, Medicetty S, Dutta R, Kidd G, Macklin WB, Trapp B.

Exp Neurol. 2016 Sep;283(Pt A):330-40. doi: 10.1016/j.expneurol.2016.06.033. Epub 2016 Jul 3.

Supplemental Content

Support Center